About Botiss biomaterials
Botiss Biomaterials: Revolutionizing the Field of Implantology and Oral Surgery
Botiss Biomaterials is a leading provider of innovative biomaterial solutions for implantology, oral surgery, bone grafting, and soft tissue regeneration. With a strong focus on research and development, the company has been at the forefront of developing cutting-edge products that have revolutionized the field of dentistry.
Founded in 2003 by Dr. Peter Geistlich, Botiss Biomaterials has grown to become one of the most trusted names in dental biomaterials. The company's mission is to provide clinicians with high-quality products that enable them to achieve optimal clinical outcomes for their patients.
Botiss Biomaterials offers a comprehensive portfolio of products that are designed to meet the needs of clinicians across different specialties. Whether you are looking for bone grafting materials or soft tissue regeneration solutions, Botiss Biomaterials has got you covered.
One of the key strengths of Botiss Biomaterials is its commitment to research and development. The company invests heavily in R&D activities to ensure that its products are always at the cutting edge of technology. This has enabled it to develop some truly groundbreaking products that have transformed how dentists approach implantology and oral surgery.
For instance, one such product is cerabone®, which is a synthetic bone substitute material made from pure-phase beta-tricalcium phosphate (β-TCP). Cerabone® has been shown to be highly effective in promoting new bone growth and can be used as an alternative to autologous bone grafting procedures.
Another innovative product from Botiss Biomaterials is mucoderm®, which is a porcine-derived collagen matrix used for soft tissue regeneration. Mucoderm® provides an excellent scaffold for cell migration and proliferation while also promoting angiogenesis (the formation of new blood vessels).
In addition to these two flagship products, Botiss Biomaterials also offers a range of other biomaterial solutions, including Jason® membrane, maxgraft®, and collacone®. All these products are designed to meet the highest standards of quality and safety.
Botiss Biomaterials has a strong global presence, with its products being used by clinicians in over 100 countries worldwide. The company has established partnerships with leading dental companies and institutions to ensure that its products are widely available to clinicians everywhere.
In conclusion, Botiss Biomaterials is a company that is dedicated to advancing the field of implantology and oral surgery through innovative biomaterial solutions. With its commitment to research and development, it is poised to continue leading the way in this exciting field for years to come.